Results 91 to 100 of about 103,527,733 (191)

Minocycline in phenotypic models of Huntington's disease

open access: yesNeurobiology of Disease, 2005
Minocycline has been shown to be neuroprotective in various models of neurodegenerative diseases. However, its potential in Huntington's disease (HD) models characterized by calpain-dependent degeneration and inflammation has not been investigated. Here,
Kadiombo Bantubungi   +15 more
doaj   +1 more source

3-Nitropropionic acid increases frataxin expression in humanlymphoblasts and in transgenic rat PC12 cells

open access: yes, 2003
Friedreich ataxia (FRDA) is the most common recessive ataxia caused by reduced expression of frataxin, a nuclear encoded mitochondrial protein. In this study we examined the effects of 3-nitropropionic acid (3-NP) on frataxin expression in FRDA patient ...
RUGGIERO, GIUSEPPINA   +7 more
core  

NR2B subunit blockade does not affect motor symptoms induced by 3-nitropropionic acid

open access: yes, 2011
Broad-spectrum N-methyl D-aspartate (NMDA) antagonists, although proposed in therapies for several pathologies including Huntington's disease (HD), can produce dramatic side-effects.
Morari, Michele   +9 more
core   +1 more source

Avaliação do potencial efeito protetor do probucol em modelos experimentais da doença de Huntington [PDF]

open access: yes, 2012
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências Biológicas. Programa de Pós-Graduação em BioquímicaA doença de Huntington (DH) é uma patologia neurodegenerativa, autossômica dominante caracterizada por sintomas ...
Colle, Dirleise
core  

Melatonin improves 3-nitropropionic acid induced behavioral alterations and neurotrophic factors levels

open access: yes, 2011
Embargado hasta 01/01/2100.Objective: This study sought to determine whether melatonin causes changes in neurotrophic factors and it protects against the mycotoxin 3-nitropropionic acid (3-NP) in brain tissue.
Delgado, María J   +23 more
core   +1 more source

3-Nitropropionic acid and 3-nitro-1-propanol in species of Astragalus

open access: yes, 1982
Leaves of nitro-bearing species of Astragalus collected from North American and European herbaria were analyzed for types of toxic aliphatic nitro compounds. The nitro compounds were extracted and hydrolized to 3-nitropropionic acid (3-NPA) or 3-nitro-1-
M. C. Williams
core   +1 more source

Evaluating sex differences in procedural learning and memory deficits caused by 3-nitropropionic acid

open access: yes, 2015
(M.A.) -- Towson University, 2017The current study attempted to evaluate sex differences in procedural learning and memory deficits in mice using intraperitoneal (i.p.) injections of 3-nitropropionic acid (3NP).
Haines, Kari M.
core   +1 more source

Circadian Dysfunction in Response to Treatment with the Mitochondrial Toxin 3-Nitropropionic Acid

open access: yesASN Neuro, 2013
Sleep disorders are common in neurodegenerative diseases including Huntington's disease (HD) and develop early in the disease process. Mitochondrial alterations are believed to play a critical role in the pathophysiology of neurodegenerative diseases. In
Takashi Kudo   +5 more
doaj   +1 more source

3−Nitropropionic Acid Exacerbates [3H]GABA Release Evoked by Glucose Deprivation in Rat Striatal Slices

open access: yes, 1996
3−Nitropropionic acid (3−NPA) is a metabolic poison that produces lesions of striatal intrinsic neurones such as γ-aminobutyric acid (GABA) neurones. This study was carried out to determine whether 3−NPA would impair the ability of striatal GABAergic ...
A Boireau, A Doble, M Meunier
core   +1 more source

Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat.

open access: yes, 2001
3-Nitropropionic acid (3NP) is a succinate dehydrogenase inhibitor classically used to create animal models of Huntington's disease (HD). However, the effects of this neurotoxin are highly variable in the Sprague-Dawley rat strain, impeding the interest ...
Schiffmann, Serge N.   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy